Evidence map›Paper›PMID 41986297›Full record

ArticleCell death discovery2026

Dysregulated nuclear Lamin B1 in DYT1 dystonia thickens nuclear lamina and disrupts 14-3-3 proteins.

Yuntian Duan, Masood Sepehrimanesh, Md Abir Hosain, Haochen Cui, Jacob Stagray, Xinggui Shen, Ying Xiao, Yuqing Li, Chun-Li Zhang, Baojin Ding

Abstract read
In one paragraph

Article in Cell death discovery, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Yuntian DuanDepartment of Biochemistry and Molecular Biology, Louisiana State University Health Sciences Center at Shreveport, Shreveport, LA, USA.ORCID http://orcid.org/0000-0001-7796-5204
Masood SepehrimaneshDepartment of Biochemistry and Molecular Biology, Louisiana State University Health Sciences Center at Shreveport, Shreveport, LA, USA.
Md Abir HosainDepartment of Biochemistry and Molecular Biology, Louisiana State University Health Sciences Center at Shreveport, Shreveport, LA, USA.ORCID http://orcid.org/0000-0002-2083-3822
Haochen CuiDepartment of Biochemistry and Molecular Biology, Louisiana State University Health Sciences Center at Shreveport, Shreveport, LA, USA.ORCID http://orcid.org/0000-0003-3590-2613
Jacob StagrayDepartment of Biology, University of Louisiana at Lafayette, Lafayette, LA, USA.
Xinggui ShenDepartment of Pathology and Translational Pathobiology, Louisiana State University Health Sciences Center at Shreveport, Shreveport, LA, USA.
Ying XiaoShared Instrumentation Facility, Louisiana State University, Baton Rouge, LA, USA.
Yuqing LiDepartment of Neurology, Norman Fixel Institute for Neurological Diseases, College of Medicine, University of Florida, Gainesville, FL, USA.ORCID http://orcid.org/0000-0003-1211-5529
Chun-Li ZhangDepartment of Molecular Biology, University of Texas Southwestern Medical Center, Dallas, TX, USA.ORCID http://orcid.org/0000-0002-2639-4605
Baojin DingDepartment of Biochemistry and Molecular Biology, Louisiana State University Health Sciences Center at Shreveport, Shreveport, LA, USA. Baojin.ding@lsuhs.edu.ORCID http://orcid.org/0000-0002-2149-2599

Funding

Supplement: Pathophysiology of DYT1 dystonia: Targeted Mouse ModelsR01NS129873 · NINDS · UNIVERSITY OF FLORIDA · PI YUQING LI · 2022 to 2026
$1.9M
Modeling DYT1 Dystonia in Patient-derived NeuronsR56NS133252 · NINDS · LOUISIANA STATE UNIV HSC SHREVEPORT · PI DING, BAOJIN · 2023 to 2023
$365k
NINDS NIH HHS R01 NS129873NINDS NIH HHS R56 NS133252U.S. Department of Health & Human Services | NIH | National Institute of Neurological Disorders and Stroke (NINDS) NS133252
6 · The paper itself

Abstract

Childhood-onset DYT1 dystonia is a severe movement disorder caused by a heterozygous ΔE mutation in TOR1A, yet the molecular mechanisms driving disease remain unclear. The nuclear lamina, a key structural scaffold for nuclear integrity and gene regulation, has emerged as a potential site of dysfunction. Here, we investigated the role of nuclear Lamin B1 dysregulation in DYT1 pathology using patient fibroblasts and human iPSC-derived neurons. We show that excess Lamin B1 thickens the nuclear lamina, distorts nuclear architecture, and impairs nucleocytoplasmic transport. Proteomic profiling further revealed that dysregulated Lamin B1 disrupts neuronal signaling pathways, with 14-3-3 proteins, highly abundant chaperones essential for neuronal development and homeostasis, being the most affected. Functional studies demonstrated that loss of 14-3-3 proteins compromises neuron differentiation, whereas restoring their levels rescues DYT1 neuronal defects by correcting Lamin B1 mislocalization. These findings establish a mechanistic link between nuclear architecture, intracellular signaling, and neuronal deficits in DYT1 dystonia, and identify Lamin B1 and 14-3-3 proteins as promising therapeutic targets with broader relevance to neurological disease.

Identifiers

PMID41986297
PMCPMC13195094

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.